Damon R. Asher, Ph.D.

Affiliations: 
2004 Harvard University, Cambridge, MA, United States 
Area:
Immunology, Molecular Biology
Google:
"Damon Asher"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Robert W. Finberg grad student 2004 Harvard
 (Characterization of the coxsackievirus and adenovirus receptor (CAR).)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang JP, Cerny A, Asher DR, et al. (2010) MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. Journal of Virology. 84: 254-60
Wang JP, Asher DR, Chan M, et al. (2007) Cutting Edge: Antibody-mediated TLR7-dependent recognition of viral RNA. Journal of Immunology (Baltimore, Md. : 1950). 178: 3363-7
Wang J, Asher D, Chan M, et al. (2007) Role of toll-like receptors in virus-mediated auto-immune disease Molecular Immunology. 44: 254-255
Finberg R, Asher D. (2007) The virus snare: Use of an anti-CR1 and virus receptor fusion protein to enhance virus clearance Molecular Immunology. 44: 169
Finberg R, Wang J, Asher D. (2006) 88 Role of toll like receptors in post viral disease International Journal of Infectious Diseases. 10: S49-S50
Asher D, Finberg R. (2005) CAR might provide a survival signal for myocardial cells. Journal of Cell Science. 118: 5679; author reply 5
Asher DR, Cerny AM, Finberg RW. (2005) The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection. Proceedings of the National Academy of Sciences of the United States of America. 102: 12897-902
Asher DR, Cerny AM, Weiler SR, et al. (2005) Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis (New York, N.Y. : 2000). 42: 77-85
Repik A, Pincus SE, Ghiran I, et al. (2005) A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clinical and Experimental Immunology. 140: 230-40
See more...